Effect of Botulinum Toxin A Injections and Specific Intensive Rehabilitation Therapy in Children with Hemiparetic Cerebral Palsy on Upper Limb Functions and Skills - BoBiVa (Botuline toxine Bimanuele Vaardigheden)

未提供0 个研究点目标入组 60 人开始时间: 2006年5月17日最近更新: 2012年3月19日

适应症

试验速览

暂无简介。

•Age 2,5 – 12 years
•Cerebral Palsy
•Hagberg diagnosis: spastic hemiparesis or extreme asymmetric diplegia
•Hand function impairment Zancolli grade I with evident problems in thumb extension and supination, Zancolli grade IIA and IIB (Zancolli E.A., 1987)
•Mentally able to comprehend and perform tasks
•Children and their parents should be able to cope with the intensive rehabilitation therapy programme and the measurement sessions
•Children and the parents/caregivers should comprehend and speak Dutch
•Children and their parents indicate the necessity for improvement of the children‘s abilities
•Are the trial subjects under 18? yes
•Number of subjects for this age range:
•F.1.2 Adults (18-64 years) no
•F.1.2.1 Number of subjects for this age range
•F.1.3 Elderly (>=65 years) no
•F.1.3.1 Number of subjects for this age range

•Severe structural contractures of the muscles at the extremity to be treated (elbow extension deficit 20 degrees, supination deficit 45 degrees, deficit wrist dorsal flexion 30 degrees or more)
•Severe impairment of hand function, no active hand function is expected after treatment (Zancolli III)
•Hand surgery to improve function, or fenolisation or btA injections in the arm less than nine months ago
•Contra indication for botulinum toxin (children with muscular diseases, like myasthenia gravis, tetanus vaccination less than 3 months before the injection, use of aminoglycoside antibiotics or spectinomycine, known hypersensitivity for human albumin)
•Contra indication for anaesthesia
•Children who cannot bare touching the affected arm and hand

发起方

未提供